Recent progress in therapeutic applications of fluorinated five-membered heterocycles and their benzo-fused systems
RSC Advances · 2024 · 14 (46) · 33864-33905
DOI: 10.1039/d4ra05697c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2024. Verfasst von Ashraf A Abbas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg (+202) 35727556. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Fluorinated five-membered heterocycles have potent therapeutic activities including antiviral, anti-inflammatory, enzymatic inhibitory, and antimalarial.
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg (+202) 35727556.
- Department of Chemistry, Faculty of Science, Umm Al-Qura University Makkah Saudi Arabia.
ORCID-Profile: Ashraf A Abbas, Thoraya A Farghaly, Kamal M Dawood
Zitieren
APA
Abbas, A. A., Farghaly, T. A., & Dawood, K. M. (2024). Recent progress in therapeutic applications of fluorinated five-membered heterocycles and their benzo-fused systems. RSC Advances, 14(46), 33864-33905. https://doi.org/10.1039/d4ra05697c
Vancouver
Abbas AA, Farghaly TA, Dawood KM. Recent progress in therapeutic applications of fluorinated five-membered heterocycles and their benzo-fused systems. RSC Advances. 2024;14(46):33864-33905. doi:10.1039/d4ra05697c
BibTeX
@article{Abbas2024,
author = {Abbas, Ashraf A and Farghaly, Thoraya A and Dawood, Kamal M},
title = {Recent progress in therapeutic applications of fluorinated five-membered heterocycles and their benzo-fused systems},
journal = {RSC Advances},
year = {2024},
volume = {14},
number = {46},
pages = {33864--33905},
doi = {10.1039/d4ra05697c}
}
EUVIMED